Niche Biopharmaceuticals
Early-stage biotechnology company developing a novel small-molecule therapeutic class described as a coupled anti-infected immunomodulatory therapeutic (CAIT). The company reports broad-spectrum antibacterial and antiviral activity, anti-inflammatory properties, issued composition-of-matter and use patents, a pre-IND interaction with the FDA (May 2024), and an initial clinical focus on atopic dermatitis with plans to support a Phase 1 trial.
Industries
Nr. of Employees
small (1-50)
Niche Biopharmaceuticals
Patents
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
US-11873272-B2
View DetailsAntimicrobial and antiviral sulfur containing glycerol monoester derivatives
US-11572342-B2
View DetailsAntimicrobial and antiviral sulfur containing glycerol monoester derivatives
US-11365176-B2
View Details
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
US-11873272-B2
View DetailsAntimicrobial and antiviral sulfur containing glycerol monoester derivatives
US-11572342-B2
View DetailsAntimicrobial and antiviral sulfur containing glycerol monoester derivatives
US-11365176-B2
View DetailsProducts
Small-molecule new chemical entity for dermatological and anti-infective indications
A novel small-molecule therapeutic class described as a coupled anti-infected immunomodulatory therapeutic with reported broad-spectrum antibacterial and antiviral activity and anti-inflammatory properties. Initial development focus is on atopic dermatitis.
Small-molecule new chemical entity for dermatological and anti-infective indications
A novel small-molecule therapeutic class described as a coupled anti-infected immunomodulatory therapeutic with reported broad-spectrum antibacterial and antiviral activity and anti-inflammatory properties. Initial development focus is on atopic dermatitis.
Expertise Areas
- Small-molecule drug discovery
- Antimicrobial and antiviral therapeutics
- Preclinical pharmacology and mechanism-of-action studies
- Regulatory strategy and FDA pre-IND interactions
Key Technologies
- Small-molecule NCE synthesis
- In vitro antibacterial assays
- In vitro antiviral assays
- Serial passaging resistance assays